Drawing for BAYESMED.AI

USPTO serial 98567725

BAYESMED.AI

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WILLIS, ALLYSON B
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BAYESMED.AI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amir V. Adibi

Amir V. Adibi Adibi IP Group, PC155 Montgomery StreetSuite 1010San Francisco, CA 94104

Goods and services

ClassDescriptionStatusFirst use
042Providing information about medical research; Providing information about medical research via a website; Providing information about medical and scientific research; Providing information about medical and scientific research via a website; Research and development in the field of patient advocacy, clinical support, and patient-clinician workflows supported by artificial intelligence; Medical and scientific research in the field of patient advocacy, clinical support, and patient-clinician workflows supported by artificial intelligence; Medical and scientific research in the field of medical information tools and workflows;  Providing temporary use of on-line non-downloadable software for accessing, reading, and tracking information in the field of patient medical recordsACTIVE—
044Consulting services in the field of medical care; Consulting services in the fields of diagnostic medical testing and nutrition; Individual medical counseling services provided to patients; Medical analysis services relating to the treatment of patients; Medical analysis services relating to the treatment of persons; Medical services; Providing a website for clinician support and patient-clinician workflows featuring medical information supported by artificial intelligence; providing medical information, including doctors and healthcare records, medical records, diagnosis and prevention information, medical research information, and patient-clinician workflows supported by artificial intelligence; Medical assistance services; Providing educational information about healthcare; Providing health information via a website; Providing information about health, wellness and nutrition via a website; Providing information in the field of mental health and wellness via a website; Providing medical information, consultancy and advisory services; Providing mental health information via a website; Providing physical health information via a website; Providing educational information in the fields of patient advocacy and clinical supportACTIVE—
045Providing case management services, namely, coordinating legal, medical, physical, social, personal care and psychological services; Providing case management services, namely, coordinating legal, medical, physical, social, personal care and psychological services for individuals, children, adults, elderly, and disabled persons; Providing case management services, namely, coordinating legal, physical, social and psychological services for disabled persons; Providing case management services, namely, coordinating legal, physical, social and psychological services for individuals, children, adults, elderly, and disabled persons; Providing information about legal eligibility requirements for government medical and pharmaceutical programs; Providing patient advocate services in the field of healthcare, including all sub-disciplines of healthcare; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication; Providing personal support services for families of patients with life threatening disorders, namely, companionship, help with medical forms, emotional counseling and emotional support; Providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support; Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support; Verifying and monitoring the credentials of doctors and other medical professionals for public safety purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 29, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 29, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 19, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 19, 2025EX1GSOU EXTENSION 1 GRANTED—
Nov 18, 2025EXT1SOU EXTENSION 1 FILED—
Nov 18, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 27, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 1, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 1, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 26, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 5, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 5, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Mar 5, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 5, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 5, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 9, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2024DOCKASSIGNED TO EXAMINER—
Dec 2, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 24, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance